Published in J Med Genet on December 01, 2000
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet (2011) 1.25
Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. Hum Mol Genet (2008) 0.94
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet (2006) 0.89
Neurofibromatosis: chronological history and current issues. An Bras Dermatol (2013) 0.77
Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas? Childs Nerv Syst (2011) 0.77
Height assessments in children with neurofibromatosis type 1. J Child Neurol (2012) 0.77
Secondary Knee Osteoarthritis due to Neurofibromatosis Type 1 Treated with above the Knee Amputation: A Case Report. Case Rep Orthop (2013) 0.76
Dystrophic spinal deformities in a neurofibromatosis type 1 murine model. PLoS One (2015) 0.75
Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet (2017) 0.75
Sarcomas in children with neurofibromatosis type 1-poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution. Childs Nerv Syst (2007) 0.75
Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth. Hum Genet (2017) 0.75
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain (1988) 4.69
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42
Neurofibromatosis type 1 growth charts. Am J Med Genet (1999) 2.32
Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science (1997) 2.30
Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects Orig Artic Ser (1979) 1.85
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
Head circumference charts updated. Arch Dis Child (1985) 1.69
Is double data entry necessary? The CHART trials. CHART Steering Committee. Continuous, Hyperfractionated, Accelerated Radiotherapy. Control Clin Trials (1994) 1.64
An assessment of data quality in the Vermont-Oxford Trials Network database. Control Clin Trials (1995) 1.45
Growth hormone replacement and the risk of malignancy in children with neurofibromatosis. J Pediatr (1998) 1.44
Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science (1997) 1.38
von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology (1984) 1.32
Single vs. double data entry in CAST. Control Clin Trials (1992) 1.21
cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways. J Neurosci Res (1997) 1.18
Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett (1996) 1.01
Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. J Neurosci (1993) 0.95
Segregation analysis of peripheral neurofibromatosis (NF1). J Med Genet (1990) 0.93
Secular trends in human growth, maturation, and development. Monogr Soc Res Child Dev (1979) 0.91
Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. Brain Res (1999) 0.89
Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics (1997) 0.88
Induction of oligodendrocyte differentiation by activators of adenylate cyclase. J Neurosci Res (1990) 0.87
Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study. Pediatrics (1999) 0.86
Oligodendrocyte differentiation and progenitor cell proliferation are independently regulated by cyclic AMP. J Neurosci Res (1993) 0.83
National Neurofibromatosis Foundation International Database. Am J Med Genet (1993) 0.83
Macrocranium and neurofibromatosis. Radiology (1973) 0.79
Serum mitogenic activity on in vitro glial cells in Neurofibromatosis type 1. Brain Res (1998) 0.78
Effects of intracellular cyclic AMP and cyclic GMP levels on DNA synthesis of young-adult rat hepatocytes in primary culture. Exp Cell Res (1992) 0.78
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
Abnormal splicing of the leptin receptor in diabetic mice. Nature (1996) 7.71
Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell (2000) 5.73
Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet (1996) 4.84
Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev (2000) 4.57
Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I. Science (1988) 4.50
Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest (2001) 3.82
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A (1997) 3.81
Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol (2000) 3.60
Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci U S A (1995) 3.33
Acute stimulation of glucose metabolism in mice by leptin treatment. Nature (1997) 3.12
Cocrystal structure of an editing complex of Klenow fragment with DNA. Proc Natl Acad Sci U S A (1988) 3.02
Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science (2001) 2.98
Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem (2001) 2.91
Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet (2001) 2.78
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1994) 2.71
NF1 gene and neurofibromatosis 1. Am J Epidemiol (2000) 2.58
Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A (1997) 2.57
Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet (2000) 2.49
Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc Natl Acad Sci U S A (1994) 2.47
Crystal structures of the Klenow fragment of DNA polymerase I complexed with deoxynucleoside triphosphate and pyrophosphate. Biochemistry (1993) 2.19
Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics (2003) 2.11
A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha. J Med Genet (2007) 1.94
Drug safety in pregnant women and their babies: ignorance not bliss. Clin Pharmacol Ther (2007) 1.87
Linkage of functional and structural heterogeneity in proteins: dynamic hole burning in carboxymyoglobin. Science (1987) 1.87
Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A (1997) 1.85
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet (2003) 1.85
Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology (2006) 1.85
Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children. Neurology (2000) 1.83
On the use of population attributable fraction to determine sample size for case-control studies of gene-environment interaction. Epidemiology (2003) 1.82
Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics (2000) 1.79
Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol (2002) 1.76
Assessment of algorithms for high throughput detection of genomic copy number variation in oligonucleotide microarray data. BMC Bioinformatics (2007) 1.75
Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol Cell Biol (1986) 1.73
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet (2000) 1.70
A reevaluation of risk of in utero exposure to lithium. JAMA (1994) 1.68
Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet A (2005) 1.68
Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet (2011) 1.68
Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered (2001) 1.67
Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology (2005) 1.65
Transcriptional and post-transcriptional control of specific messenger RNAs in adult and embryonic liver. J Mol Biol (1984) 1.63
Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation (2006) 1.58
Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology (2002) 1.53
Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet (1990) 1.53
Ordered water molecules as key allosteric mediators in a cooperative dimeric hemoglobin. Proc Natl Acad Sci U S A (1996) 1.51
Update on new developments in the study of human teratogens. Teratology (2002) 1.49
Excited state lifetimes in cytochromes measured from Raman scattering data: evidence for iron-porphyrin interactions. Proc Natl Acad Sci U S A (1977) 1.48
Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr (2007) 1.46
Transient Raman study of CO-haemoprotein photolysis: origin of the quantum yield. Nature (1980) 1.43
A microplate system for ABO and Rh(D) blood grouping. Transfusion (1993) 1.43
Workshop report: evaluation of genetic and epigenetic risks associated with assisted reproductive technologies and infertility. Fertil Steril (2007) 1.42
Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet (1999) 1.40
Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet (2002) 1.37
del(20p) with manifestations of arteriohepatic dysplasia. Am J Med Genet (1986) 1.35
The iron-proximal histidine linkage and protein control of oxygen binding in hemoglobin. A transient Raman study. J Biol Chem (1983) 1.35
Saethre-Chotzen syndrome: a broad and variable pattern of skeletal malformations. J Pediatr (1977) 1.35
Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug Chem (2003) 1.34
Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem (1996) 1.31
Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet (1988) 1.31
Rat obesity gene fatty (fa) maps to chromosome 5: evidence for homology with the mouse gene diabetes (db). Proc Natl Acad Sci U S A (1991) 1.30
Structure, dynamics, and reactivity in hemoglobin. Science (1985) 1.29
Gene expression during liver regeneration. J Mol Biol (1984) 1.27
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology (2002) 1.25
Protein-heme interaction in hemoglobin: evidence from Raman difference spectroscopy. Proc Natl Acad Sci U S A (1979) 1.24
Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr (2008) 1.23
Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci U S A (1999) 1.23
Teratology Society Consensus Statement on use of folic acid to reduce the risk of birth defects. Teratology (1997) 1.19
Chronic neuropathic pain in treated leprosy. Lancet (2000) 1.19
Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum (1986) 1.18
Genetic disease in the offspring of older fathers. Obstet Gynecol (1981) 1.17
Heme-heme interactions in a homodimeric cooperative hemoglobin. Evidence from transient Raman scattering. J Biol Chem (1993) 1.17
Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol (2005) 1.17
Structural studies of Klenow fragment: an enzyme with two active sites. Cold Spring Harb Symp Quant Biol (1987) 1.16
Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med (1997) 1.16
Molecular mapping of the mouse db mutation. Proc Natl Acad Sci U S A (1990) 1.14
Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr (2006) 1.14
Capillary hemangioma of the maxilla. A report of two cases in which angiography and embolization were used. Oral Surg Oral Med Oral Pathol (1990) 1.13
The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res (1995) 1.13
The alphabet of weight control. Nature (1997) 1.13
Nanosecond transient Raman spectra of photolysed carboxyhaemoglobin. Nature (1978) 1.12
Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci U S A (1996) 1.12
Increased dental caries in people with neurofibromatosis 1. Clin Genet (2007) 1.10
Autoimmunity in the relatives of patients with immunodeficiency diseases. Clin Exp Immunol (1977) 1.10
Sol-gel trapping of functional intermediates of hemoglobin: geminate and bimolecular recombination studies. Biochemistry (2000) 1.09
Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix. Mol Biol Med (1990) 1.08
Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Genet Epidemiol (2002) 1.08
Biochemical abnormalities in rhizomelic chondrodysplasia punctata. J Pediatr (1988) 1.08
Two DNA polymerases: HIV reverse transcriptase and the Klenow fragment of Escherichia coli DNA polymerase I. Cold Spring Harb Symp Quant Biol (1993) 1.07
Localized control of ligand binding in hemoglobin: effect of tertiary structure on picosecond geminate recombination. Science (1985) 1.07
Molecular genetic linkage maps of mouse chromosomes 4 and 6. Genomics (1991) 1.06
Genetics and epidemiology, congenital anomalies and cancer. Am J Hum Genet (1997) 1.06
Do geneticists need Babel fish? Genet Med (2001) 1.06
Beta 93 modified hemoglobin: kinetic and conformational consequences. Biochemistry (2001) 1.06
Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet (2008) 1.06